Is the Benefit From Prescribing Epinephrine Autoinjectors for Sublingual Immunotherapy Worth the Cost? Lessons Learned From Clinical Trials

J Allergy Clin Immunol Pract. 2017 Jan-Feb;5(1):90-91. doi: 10.1016/j.jaip.2016.11.008.

Authors

Jay Portnoy¹, Linda S Cox²

Affiliations

¹ Section of Allergy, Asthma, and Immunology, Children's Mercy Hospital, Kansas City, Mo; Department of Pediatrics, University of Missouri - Kansas City School of Medicine, Kansas City, Mo.
² Department of Medicine, University of Miami Miller School of Medicine at Holy Cross Hospital, Ft Lauderdale, Fla. Electronic address: lindaswolfcox@msn.com.

PMID: 28065345
DOI: 10.1016/j.jaip.2016.11.008

No abstract available

Publication types

Editorial
Comment

MeSH terms

Anaphylaxis*
Epinephrine
Humans
Immunotherapy
Injections
Sublingual Immunotherapy*

Substances

Epinephrine